Description
Pancragen
Buy Pancragen Online
Pancragen is a short peptide associated with the Khavinson family of organ-specific bioregulatory peptides. It is commonly described as a tetrapeptide associated with pancreatic tissue and has attracted interest in research involving glucose metabolism, insulin regulation, and age-related pancreatic function.
Unlike established diabetes medications, Pancragen has a very limited international clinical evidence base.
Product Information
Pancragen is generally identified as the tetrapeptide Lys-Glu-Asp-Trp (KEDW). Research has investigated its possible influence on pancreatic endocrine function and glucose metabolism.
Animal research has reported effects on glucose, insulin, and C-peptide levels, including studies in aged rhesus monkeys.
How Does It Work?
The proposed mechanism involves modulation of pancreatic cellular and regulatory processes. The exact molecular mechanism remains uncertain, and claims that Pancragen directly regulates pancreatic gene expression are largely based on the bioregulator research framework rather than independently established pharmacology.
Benefits
Pancreatic Function Research
Pancragen’s primary research interest centers on pancreatic tissue and endocrine function, distinguishing it from bioregulators aimed at other organs.
Glucose-Metabolism Research
Animal research has reported improvements in impaired glucose tolerance and changes in insulin and C-peptide levels following Pancragen treatment.
Insulin Signaling Interest
Changes in insulin and C-peptide observed in experimental models have made Pancragen interesting for research into pancreatic endocrine regulation.
Age-Related Metabolic Research
Some of the most frequently cited work involves older animal models, supporting interest in Pancragen as a compound for studying age-associated changes in pancreatic and metabolic function.
Side Effects
Reliable human safety data are limited. Potential risks of manipulating glucose-regulatory pathways include excessive glucose lowering, metabolic disturbances, and unknown long-term effects.
Because commercially marketed Pancragen preparations may differ in formulation, product quality and identity should also be considered.
Dosage
There is no approved clinical dosing regimen for Pancragen.
Published animal work has used 0.05 mg per animal per day for approximately 10 days in aged rhesus monkeys.
Online sources also describe market protocols ranging from approximately 1–2 mg daily for 10–20 days, but these figures are commercial/community practices rather than validated human dosing.
Where to Buy Pancragen
Purerawz does not sell or directly supply Pancragen. Where available, links may direct readers to independent third-party providers through affiliate relationships.
References
1. Goncharova ND, et al. Correction of impaired glucose tolerance using Pancragen in old rhesus monkeys.
PubMed — PMID: 28509500
2. Pancragen research evidence and safety profile. Research literature summary.
Disclaimer
Purerawz does not sell, manufacture, stock, dispense, or directly supply any of the products discussed on this website. Purerawz is an independent information and affiliate platform. Where available, links may direct readers to independent third-party providers, and Purerawz may receive a commission from qualifying purchases at no additional cost to the reader.
The information is for educational and informational purposes only. Dosage figures may reflect published research, historical clinical protocols, or reported market practices and should not be interpreted as personalized medical instructions.
Reviews
There are no reviews yet.